Cardiovascular Imaging with PET, CT, and MR Imaging

Area of Science:

• Medical Imaging
• Cardiovascular Science
• Nuclear Medicine

Background:

• Positron Emission Tomography (PET) offers high-resolution in vivo imaging of radiopharmaceutical biodistribution.
• Fluorine-18-labeled fluorodeoxyglucose (FDG)-PET is widely used in oncology and increasingly for inflammatory, cardiac, and neurologic conditions.
• Advances in CT and MR imaging complement PET for comprehensive cardiovascular assessment.

Purpose of the Study:

• To review the applications of PET, CT, and MR imaging in evaluating the cardiovascular system.
• To highlight the role of FDG-PET in assessing myocardial viability and other cardiac pathologies.
• To discuss the advancements in imaging technologies for cardiovascular diagnostics.

Main Methods:

• Review of current literature and established applications of PET, CT, and MR imaging in cardiology.
• Focus on FDG-PET for myocardial perfusion and metabolism imaging.
• Integration of imaging modalities for comprehensive cardiovascular evaluation.

Main Results:

• FDG-PET is the gold standard for noninvasive assessment of myocardial viability.
• Combined imaging modalities provide advanced insights into cardiovascular pathologies.
• MR imaging offers a comprehensive approach to cardiac evaluation.

Conclusions:

• PET, CT, and MR imaging are essential tools for modern cardiovascular evaluation.
• These imaging techniques are vital for diagnosing and managing a range of cardiac conditions.
• Technological advancements continue to enhance noninvasive cardiovascular assessment.